Company news
bioMerieux SA news in 2026
bioMerieux SA's news releases, calls and decks from 2026, newest first.
bioMerieux: Exor to raise its stake in biomérieux
November 19, 2026
Exor-Institut Mérieux-bioMérieux Press Release
November 19, 2026
bioMérieux receives U.S. FDA 510(k) Clearance and IVDR CE marking for VITEK® PRO, its new automated ID/AST instrument to support the fight against antimicrobial resistance
November 9, 2026
bioMérieux – Third-Quarter 2026 Business Review
November 2, 2026
bioMérieux – Information financière du 3ème trimestre 2026
November 2, 2026
Octobre 2026 - Déclaration sur le nombre d\'actions composant le capital social et sur le nombre de droits de vote correspondant
November 1, 2026
bioMérieux receives Dual 510(k) Clearance and CLIA Waiver from the FDA for the BIOFIRE® SPOTFIRE® Vaginitis Panel to Advance Women’s Health with Rapid Molecular Diagnostics
October 21, 2026
WHO Grants Emergency Use Listing for BIOFIRE Global Fever Special Pathogens Panel, Expanding Access to Differential Diagnostics for the Ebola Response
October 19, 2026
WHO Grants Emergency Use Listing for BIOFIRE® Global Fever Special Pathogens Panel, Expanding Access to Differential Diagnostics for the Ebola Response
October 18, 2026
Septembre 2026 - Déclaration sur le nombre d\'actions composant le capital social et sur le nombre de droits de vote correspondant
September 30, 2026
bioMerieux: BioMérieux Receives IVDR Class D CE Marking for BIOFIRE® Respiratory 2.1 plus Panel and BIOFIRE® FILMARRAY® Pneumonia plus Panel, the first syndromic tests including MERS-CoV to achieve this certification
September 16, 2026
bioMérieux Highlights Positive Impacts of Rapid, Accurate Diagnostics for Patients and Accepts Industry Awards at ADLM 2026
August 7, 2026
BioMérieux – First-Half 2026 Results
July 28, 2026
bioMérieux introduces Salmonella testing kit on GENE-UP® TYPER to support root cause analysis in the food industry
June 18, 2026
AG 2026 - 2025 Parent company financial statements
May 4, 2026
AG 2026 - 2025 Consolidated financial statements
May 4, 2026
AG 2026 - Statutory auditors' report - 2025 Parent company annual financial statements
May 4, 2026
AG 2026 - Statutory auditors' report - 2025 consolidated financial statements
May 4, 2026
BioMérieux – First-Quarter 2026 Business Review
April 23, 2026
First-Quarter 2026 Business Review
April 23, 2026
First-of-its-Kind Health Economic Analysis Shows Early Use of Fast Diagnostics in Sepsis Care Could Save Thousands of Lives and Reduce Health System Costs Across G7 Countries
April 20, 2026
BioMérieux Unveils its BIOFIRE® SPOTFIRE® Molecular Testing Solution for the Pharmaceutical Industry, Redefining Rapid Mycoplasma Testing
April 9, 2026
Communiqué de mise à disposition du Document d'enregistrement universel 2025 incluant le Rapport Financier Annuel
March 17, 2026
bioMérieux launches SMARTBIOME™ to help food manufacturers gain deeper insights into spoilage and protect product quality
February 18, 2026
Commonwealth Fusion Systems Names Stephane Bancel to Board of Directors
January 12, 2026
Calls in 2026
Decks in 2026
- H1 2026 Earnings Presentation
Earnings · 35 slides · Jul 28, 2026
- Shareholder Meeting (May 2026)
Shareholder meeting · 92 slides · May 28, 2026
- FY2025 Earnings Presentation
Earnings · 26 slides · Feb 27, 2026
- 44th Annual J.P. Morgan Healthcare Conference (January 2026)
Conference · 20 slides · Jan 13, 2026